Building on more than 40 years of experience, we work with our network of researchers and public health practitioners in low- and middle-income countries (LMICs) to ensure that more scientific evidence is generated and translated into safe, effective, equitable and accessible health solutions for populations suffering from infectious diseases of poverty. This often means studying how interventions that work in clinical trials and pilot settings can be transferred to “real life” settings and scaled up at the national level.

We fund research that national and international programmes have identified as priorities for overcoming obstacles and bridging gaps on the path from innovation to implementation, access and health impact.

Over the years, TDR has established research networks and collaborations in low- and middle-income countries that in 2020 have played a key role in mitigating the impact of the COVID-19 pandemic on various disease control efforts. This experience has highlighted the benefits of long-term investments that have built capacities within research and public health communities and mechanisms in LMICs that can be activated to respond effectively in times of health emergencies.